DE69331230T2 - VERWENDUNG VON rETINOESÄURE ZUR HERSTELLUNG EINES ARZNEIMITTELS ZUR BEHANDLUNG VON HYPERPIGMENTIERUNG BEI SCHWARZER HAUT UND VERFAHREN ZUM AUFHELLEN SCHWARZER HAUT MIT RETINOESÄURE - Google Patents
VERWENDUNG VON rETINOESÄURE ZUR HERSTELLUNG EINES ARZNEIMITTELS ZUR BEHANDLUNG VON HYPERPIGMENTIERUNG BEI SCHWARZER HAUT UND VERFAHREN ZUM AUFHELLEN SCHWARZER HAUT MIT RETINOESÄUREInfo
- Publication number
- DE69331230T2 DE69331230T2 DE69331230T DE69331230T DE69331230T2 DE 69331230 T2 DE69331230 T2 DE 69331230T2 DE 69331230 T DE69331230 T DE 69331230T DE 69331230 T DE69331230 T DE 69331230T DE 69331230 T2 DE69331230 T2 DE 69331230T2
- Authority
- DE
- Germany
- Prior art keywords
- retinoic acid
- black skin
- lightening
- producing
- medicinal product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 title 2
- 229930002330 retinoic acid Natural products 0.000 title 2
- 229960001727 tretinoin Drugs 0.000 title 2
- 208000000069 hyperpigmentation Diseases 0.000 title 1
- 230000003810 hyperpigmentation Effects 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 206010036229 Post inflammatory pigmentation change Diseases 0.000 abstract 3
- 230000035876 healing Effects 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 abstract 2
- 102000002004 Cytochrome P-450 Enzyme System Human genes 0.000 abstract 1
- 108010015742 Cytochrome P-450 Enzyme System Proteins 0.000 abstract 1
- 239000007844 bleaching agent Substances 0.000 abstract 1
- 230000015556 catabolic process Effects 0.000 abstract 1
- 238000006731 degradation reaction Methods 0.000 abstract 1
- 239000007854 depigmenting agent Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 150000004492 retinoid derivatives Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/861,133 US5750570A (en) | 1992-03-31 | 1992-03-31 | Method of treatment of hyperpigmentation in black skin with retinoic acid and method of lightening black skin with retinoic acid |
PCT/US1993/002711 WO1993019743A1 (en) | 1992-03-31 | 1993-03-31 | Method of treatment of hyperpigmentation in black skin with retinoic acid and method of lightening black skin with retinoic acid |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69331230D1 DE69331230D1 (de) | 2002-01-10 |
DE69331230T2 true DE69331230T2 (de) | 2002-08-29 |
Family
ID=25334976
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69331230T Expired - Fee Related DE69331230T2 (de) | 1992-03-31 | 1993-03-31 | VERWENDUNG VON rETINOESÄURE ZUR HERSTELLUNG EINES ARZNEIMITTELS ZUR BEHANDLUNG VON HYPERPIGMENTIERUNG BEI SCHWARZER HAUT UND VERFAHREN ZUM AUFHELLEN SCHWARZER HAUT MIT RETINOESÄURE |
Country Status (8)
Country | Link |
---|---|
US (2) | US5750570A (de) |
EP (1) | EP0633773B1 (de) |
AT (1) | ATE209484T1 (de) |
AU (1) | AU3931993A (de) |
DE (1) | DE69331230T2 (de) |
ES (1) | ES2169041T3 (de) |
SG (1) | SG50440A1 (de) |
WO (1) | WO1993019743A1 (de) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5750570A (en) * | 1992-03-31 | 1998-05-12 | The Regents Of The University Of Michigan | Method of treatment of hyperpigmentation in black skin with retinoic acid and method of lightening black skin with retinoic acid |
US5401517A (en) * | 1993-11-15 | 1995-03-28 | Elizabeth Arden Company, Division Of Conopco, Inc. | Cosmetic method for treatment of skin |
US5599548A (en) * | 1995-05-08 | 1997-02-04 | Elizabeth Arden Co., Division Of Conopco, Inc. | Skin care compositions containing fatty acid amides and retinol or retinyl ester |
US5536740A (en) * | 1995-06-01 | 1996-07-16 | Elizabeth Arden Company, Division Of Conopco, Inc. | Skin care compositions containing dimethyl imidazolidinone and retinol or retinyl ester |
US6183774B1 (en) | 1996-01-31 | 2001-02-06 | Collaborative Laboratories, Inc. | Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts |
US5716627A (en) * | 1996-04-25 | 1998-02-10 | Elizabeth Arden Co., Division Of Conopco, Inc. | Skin care compositions containing fatty acid amides, azoles, and retinol or retinyl ester |
US5693330A (en) * | 1996-04-25 | 1997-12-02 | Elizabeth Arden Co., Division Of Conopco, Inc. | Skin care compositions containing melinamide and a retinoid |
US5744148A (en) * | 1996-09-20 | 1998-04-28 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Stabilization of an unstable retinoid in oil-in-water emulsions for skin care compositions |
US5955092A (en) * | 1996-09-27 | 1999-09-21 | Elizabeth Arden Co., Division Of Conopco, Inc. | Skin care compositions containing an n-substituted fatty acid amide and retinol or retinyl ester |
US8541469B2 (en) * | 1997-08-23 | 2013-09-24 | Glaxo Group Limited | Treatment of cell-mediated immune diseases |
EP0908179A1 (de) * | 1997-08-23 | 1999-04-14 | Werner Bollag | Behandlung von zellvermittelten Immunkrankheiten |
GB9918022D0 (en) | 1999-07-30 | 1999-09-29 | Unilever Plc | Skin care composition |
AP2002002534A0 (en) * | 1999-11-09 | 2002-06-30 | Univ Michigan Regents | A method of treating and lightening hyperpigmentation in black skin with a retinoid. |
WO2001066080A1 (en) * | 2000-03-07 | 2001-09-13 | Avon Products, Inc. | Methods using phytol to improve the appearance of skin and compositions for such methods |
US20040043044A1 (en) | 2000-06-30 | 2004-03-04 | Granger Stewart Paton | Skin conditioning compositions containing compounds for mimicking the effect on skin of retinoic acid |
US20050154407A1 (en) * | 2000-12-20 | 2005-07-14 | Fox Hollow Technologies, Inc. | Method of evaluating drug efficacy for treating atherosclerosis |
US6949247B2 (en) | 2000-12-28 | 2005-09-27 | Unilever Home & Personal Care Usa Division Of Conopco, Inc. | Stable skin care compositions containing a retinoid and a retinoid booster system |
US6565864B2 (en) | 2000-12-28 | 2003-05-20 | Unilever Home & Personal Care Usa, A Division Of Conopco, Inc. | Skin care product containing retinoids and phytoestrogens in a dual compartment package |
WO2004043469A1 (en) | 2001-11-16 | 2004-05-27 | Klysz Beatrice M | Anti-aging skin care composition and uses thereof |
US20030212077A1 (en) * | 2002-05-08 | 2003-11-13 | Birnbaum Jay E. | Methods and compositions for treating tinea versicolor using combinations of retinoids and certain antifungals |
JP2004020220A (ja) * | 2002-06-12 | 2004-01-22 | Pioneer Electronic Corp | 通信システム及び方法、通信端末装置、通信センタ装置、並びにコンピュータプログラム |
DE102004016250A1 (de) * | 2004-04-02 | 2005-10-20 | Merck Patent Gmbh | Chromon-Komplexe |
US7794413B2 (en) * | 2005-04-19 | 2010-09-14 | Ev3, Inc. | Libraries and data structures of materials removed by debulking catheters |
DE102007013366A1 (de) | 2007-03-16 | 2008-09-18 | Merck Patent Gmbh | Verwendung von Chroman-4-on-Derivaten |
EP1977743B1 (de) | 2007-03-20 | 2009-09-02 | Johnson & Johnson Consumer France SAS | Zusammensetzung enthältend Retinoid und Beta-aminoisobuttersäurederivate |
ES2327201B1 (es) | 2008-04-23 | 2010-07-23 | Ignacio Umbert Millet | Composicion farmaceutica personalizada para el rejuvenecimiento de la piel que contiene acido retinoico. |
DE102010054149A1 (de) | 2010-12-10 | 2012-06-14 | Merck Patent Gmbh | 2-Pyrone |
ES2378028B1 (es) | 2012-02-22 | 2013-02-18 | Ignacio Umbert Millet | Composición cosmética para el rejuvenecimiento de la piel y procedimiento y usos correspondientes |
FR3067933B1 (fr) * | 2017-06-21 | 2020-07-17 | L'oreal | Modulateurs de l’opsine 3 dans la modulation de la pigmentation de la peau |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5750570A (en) * | 1992-03-31 | 1998-05-12 | The Regents Of The University Of Michigan | Method of treatment of hyperpigmentation in black skin with retinoic acid and method of lightening black skin with retinoic acid |
US5266307A (en) * | 1992-03-31 | 1993-11-30 | The Regents Of The University Of Michigan | Retinoic acid as a skin tanning agent in persons of light skin color |
-
1992
- 1992-03-31 US US07/861,133 patent/US5750570A/en not_active Expired - Fee Related
-
1993
- 1993-03-31 DE DE69331230T patent/DE69331230T2/de not_active Expired - Fee Related
- 1993-03-31 EP EP93908528A patent/EP0633773B1/de not_active Expired - Lifetime
- 1993-03-31 SG SG1996001514A patent/SG50440A1/en unknown
- 1993-03-31 AU AU39319/93A patent/AU3931993A/en not_active Abandoned
- 1993-03-31 AT AT93908528T patent/ATE209484T1/de active
- 1993-03-31 ES ES93908528T patent/ES2169041T3/es not_active Expired - Lifetime
- 1993-03-31 WO PCT/US1993/002711 patent/WO1993019743A1/en active IP Right Grant
-
1998
- 1998-05-12 US US09/076,355 patent/US6017960A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5750570A (en) | 1998-05-12 |
EP0633773B1 (de) | 2001-11-28 |
DE69331230D1 (de) | 2002-01-10 |
WO1993019743A1 (en) | 1993-10-14 |
SG50440A1 (en) | 1998-07-20 |
US6017960A (en) | 2000-01-25 |
EP0633773A4 (de) | 1994-11-09 |
AU3931993A (en) | 1993-11-08 |
EP0633773A1 (de) | 1995-01-18 |
ATE209484T1 (de) | 2001-12-15 |
ES2169041T3 (es) | 2002-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69331230D1 (de) | VERWENDUNG VON rETINOESÄURE ZUR HERSTELLUNG EINES ARZNEIMITTELS ZUR BEHANDLUNG VON HYPERPIGMENTIERUNG BEI SCHWARZER HAUT UND VERFAHREN ZUM AUFHELLEN SCHWARZER HAUT MIT RETINOESÄURE | |
WANG et al. | The effect of glycolic acid on the treatment of acne in Asian skin | |
US6300369B1 (en) | Hydroxy-kojic acid skin peel | |
GB9220667D0 (en) | Improvements in or relating to dioic acids | |
DE69423911T2 (de) | Neue retinoidkonjugate zur behandlung von alterserscheinungen der haut | |
Cotellessa et al. | The use of chemical peelings in the treatment of different cutaneous hyperpigmentations | |
NZ331237A (en) | Superficial chemical skin peels using salicyclic acid | |
Humphreys et al. | Treatment of photodamaged skin with trichloroacetic acid and topical tretinoin | |
DE69927507D1 (de) | Zusammensetzungen und verfahren zur behandlung von abnormaler zellvermehrung | |
DE69407785T2 (de) | Benzoylbenzofuranderivate zur behandlung von herzarrhythmia | |
AU3142195A (en) | Dermatological compositions containing benzoyl peroxide and a compound reducing skin irritation | |
NO912151L (no) | Essensiell-fettsyre-behandling. | |
NZ321429A (en) | Complementary compositions like polyol fatty acid polyesters for improving the performance of long-wearing cosmetic products and methods therefore | |
AU5471190A (en) | Method of topically treating acne vulgaris | |
DE59005469D1 (de) | Verfahren zur herstellung von dmt-zwischenprodukt bestimmter reinheit sowie dessen weiterverarbeitung zu reinst-dmt und/oder mittel- oder hochreiner terephthalsäure. | |
Harris et al. | Combining manual dermasanding with low strength trichloroacetic acid to improve actinically injured skin | |
ATE235502T1 (de) | Verfahren zur herstellung von di- und höheroxidierten carbonsäuren von kohlenhydraten, kohlenhydratderivaten oder primären alkoholen | |
GR3037031T3 (en) | Dermatological preparation and method for treating actinic keratoses | |
BR0313370A (pt) | composição despigmentante para a pele, uso de uma composição despigmentante para a pele, uso cosmético da mesma e método para um tratamento cosmético não terapêutico para embelezar a pele | |
MY130044A (en) | Retinoid composition | |
EP0803247A3 (de) | Retinoide enthaltende Hautpflegepräparate | |
ATA27276A (de) | Verfahren zur herstellung eines tretinoin enthaltenden mittels zur oertlichen behandlung von akne | |
AU8173094A (en) | Oxidative hair dyeing process with dihydroxybenzenes and aminoethanethiols | |
AP2002002534A0 (en) | A method of treating and lightening hyperpigmentation in black skin with a retinoid. | |
DE3774742D1 (de) | Verfahren zur herstellung von ethylenischen carbonylverbindungen. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |